CD8A and cancer: Because IFN signaling also regulates MHC-I expression in an auto and paracrine manner, dysregulation of the type I IFN signaling might also contribute to lower MHC-I expression on the surface of adjacent aneuploid cancer cells and reduce CD8+ T cell recognition of tumors.